A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

Clinical trial NCT07765511 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07765511
Sponsor: Eli Lilly and Company
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2026-10-01
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.